US Broker Ratings

Denali Therapeutics Inc. (DNLI) Investor Outlook: Exploring the 45.58% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is making waves with a compelling potential upside of 45.58%, attracting significant attention from..

Twist Bioscience (TWST) Investor Outlook: Navigating a 6.89% Upside in the Dynamic Healthcare Sector

Twist Bioscience Corporation (NASDAQ: TWST) has been making waves in the healthcare sector, specifically within the diagnostics and research industry. With a current market capitalization of..

QuidelOrtho Corporation (QDEL)

⚠️ No article content returned.

..

Immunovant, Inc. (IMVT) Stock Analysis: Uncovering a Promising 18.57% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT) is making waves in the biotechnology sector with its innovative approach to addressing autoimmune diseases. As a clinical-stage immunology company, Immunovant focuses..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: A Potential 119% Upside Awaits

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), a trailblazer in the biotechnology sector, is garnering significant attention from investors, thanks to a promising pipeline and substantial potential upside...

Veracyte, Inc. (VCYT) Stock Analysis: 21.5% Revenue Growth Signals Strong Performance in Healthcare Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare diagnostics sector, presents an intriguing opportunity for investors seeking exposure to the rapidly evolving field of..

Agios Pharmaceuticals (AGIO) Stock Analysis: Navigating Growth with a 14.62% Potential Upside

For investors seeking exposure in the healthcare sector, particularly within the biotechnology industry, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents a compelling opportunity. With a market capitalization..

HUTCHMED (China) Limited (HCM) Stock Analysis: Is a 102% Upside Within Reach for This Healthcare Innovator?

HUTCHMED (China) Limited (NASDAQ: HCM), a Hong Kong-based leader in the healthcare sector, is capturing the attention of investors with its compelling growth potential. Specializing in..

Acadia Healthcare (ACHC) Stock Analysis: What Investors Need to Know Amidst Strong Analyst Consensus

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent player in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: 15.45% Potential Upside Awaits Investors

Kymera Therapeutics, Inc. (NASDAQ: KYMR) stands out in the biotechnology sector with its innovative approach to developing small molecule therapeutics that degrade disease-causing proteins. Headquartered in..

Addus HomeCare Corporation (ADUS) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS) is capturing investor attention with its robust position in the healthcare sector, particularly within the medical care facilities industry. With a..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring Nearly 100% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company specializing in treatments for rare and ultra-rare genetic diseases, presents an intriguing opportunity for investors, boasting a potential..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with 21% Upside Potential

For investors keen on the healthcare sector, particularly the cutting-edge world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) offers a compelling opportunity. With a market..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Powerhouse with 57% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a key player in the biotechnology sector specializing in eye care therapeutics, has captured the attention of the investment community with..

GeneDx Holdings Corp. (WGS) Stock Analysis: A 35% Potential Upside in the Diagnostics Sector

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector specializing in diagnostics and research, is positioning itself as a compelling opportunity for investors..

Warby Parker Inc. (WRBY) Stock Analysis: Potential 21% Upside Beckons Investors

Warby Parker Inc. (NYSE: WRBY) stands as a distinctive player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for revolutionizing the..

Vericel Corporation (VCEL) Stock Analysis: A Biotech Powerhouse with 26% Potential Upside

Vericel Corporation (NASDAQ: VCEL) is making waves in the biotechnology sector, particularly within the niche markets of sports medicine and burn care. This commercial-stage biopharmaceutical company,..

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 23% Upside Potential in Biotech Innovation

CG Oncology, Inc. (NASDAQ: CGON) stands at the forefront of innovation in the biotechnology sector, focusing on the development of groundbreaking therapies for bladder cancer. With..

Envista Holdings (NVST) Stock Analysis: A Healthcare Gem with a 10.47% Upside Potential

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specializes in the development and sale of dental products, offering a diverse portfolio under..

Ardent Health, Inc. (ARDT) Stock Analysis: A Healthcare Contender with 10% Upside Potential

Ardent Health, Inc. (NYSE: ARDT), a prominent player in the healthcare sector, has caught the attention of investors with its robust growth trajectory and potential upside...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds